Symptomatic intracranial hemorrhage in the ALIAS Multicenter Trial: relationship to endovascular thrombolytic therapy.
about
ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2Intravenous tissue plasminogen activator before endovascular treatment increases symptomatic intracranial hemorrhage in patients with occlusion of the middle cerebral artery second division: subanalysis of the RESCUE-Japan Registry.Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke.
P2860
Symptomatic intracranial hemorrhage in the ALIAS Multicenter Trial: relationship to endovascular thrombolytic therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Symptomatic intracranial hemor ...... vascular thrombolytic therapy.
@ast
Symptomatic intracranial hemor ...... vascular thrombolytic therapy.
@en
type
label
Symptomatic intracranial hemor ...... vascular thrombolytic therapy.
@ast
Symptomatic intracranial hemor ...... vascular thrombolytic therapy.
@en
prefLabel
Symptomatic intracranial hemor ...... vascular thrombolytic therapy.
@ast
Symptomatic intracranial hemor ...... vascular thrombolytic therapy.
@en
P2860
P356
P1476
Symptomatic intracranial hemor ...... ovascular thrombolytic therapy
@en
P2093
Myron D Ginsberg
P2860
P304
P356
10.1111/IJS.12476
P577
2015-03-22T00:00:00Z